Pharmacies lose money with PBM reimbursements

Pharmacies lose money on PBM reimbursements Pharmacy Benefit Managers (PBM) are reimbursing pharmacies below cost and it’s not an isolated incident. When we asked state pharmacy associations all around the country about this problem, their members flooded our inbox. Their PBM contracts require them to dispense both generic and brand name medication to patients at…

[...]

Cooper Davis Act (S.1080) to have minimal fiscal impact.

For those following the Cooper Davis Act (S.1080) which would require social media platforms to report drug dealing when they discover it, the Congressional Budget Office has analyzed the legislation and said it will “not significantly increase net direct spending” and “not increase on-budget deficits”.

[...]

FDA Alert: Pain Relief Dietary Supplements Recalled Due to Presence of Diclofenac

Risk Statement: Consumption of undeclared diclofenac could result in serious adverse events that include cardiovascular, gastrointestinal, renal, and anaphylaxis in patients taking concomitant NSAIDs and/or anticoagulants, such as Warfarin, in those who have allergies to diclofenac, or those with underlying cardiovascular, gastrointestinal, renal, and hepatic illnesses.

[...]